EVMN Competitors & Alternatives

Compare Evommune, Inc. with similar stocks in the same industry

Biotechnology

EVMN

Main Stock
$7.24
-5.11%
Tradestie Score
29
Analyst Upside
+210.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other
Competitive Moat: None
Major Customers 0
Diversified enterprise & commercial customer base.
Critical Suppliers 0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals 0
Sole-source / monopoly positioning in sub-sector.

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ANNX Annexon, Inc. Common Stock
$3.63
-7.53%
$332.96M - 46 Compare
REPL Replimune Group, Inc.
$21.56
-1.51%
$328.62M - 26 Compare
EPRX Eupraxia Pharmaceuticals Inc. Common Stock
$7.54
-7.48%
$307.12M - 32 Compare
CADL Candel Therapeutics, Inc. Common Stock
$6.09
-1.85%
$304.12M - 47 Compare
JBIO Jade Biosciences, Inc. Common Stock
$15.52
-3.87%
$297.23M - 36 Compare
OMER Omeros Corporation
$17.18
-1.80%
$281.75M 14.9 55 Compare
DBVT DBV Technologies S.A.
$10.26
-6.85%
$275.54M - 30 Compare
VOR Vor Biopharma Inc. Common Stock
$19.26
-0.82%
$269.08M 0.1 58 Compare
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
+0.14%
$256.71M - 51 Compare
SLN Silence Therapeutics Plc American Depository Share
$19.82
-0.08%
$240.89M - 44 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC None)

217 stocks in this industry